Evidence mapPaperPMID 34226613Full record

ArticleScientific reports2021

Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults.

Hana Zahed, Mattias Johansson, Per M Ueland, Øivind Midttun, Roger L Milne, Graham G Giles, Jonas Manjer, Malte Sandsveden, Arnulf Langhammer, Elin Pettersen Sørgjerd and 29 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Kynurenine Pathway in Respiratory Diseases.International journal of tryptophan research : IJTR · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors at 20 institutions in 7 countries.

Hana ZahedGenomic Epidemiology Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008, Lyon, France.
Mattias JohanssonGenomic Epidemiology Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008, Lyon, France.
Per M UelandDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Øivind MidttunBevital AS, Bergen, Norway.
Roger L MilneCancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
Graham G GilesCancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
Jonas ManjerDepartment of Surgery, Skane University Hospital, Malmö, Sweden.
Malte SandsvedenDepartment of Clinical Sciences Malmo, Lund University, Malmö, Sweden.
Arnulf LanghammerDepartment of Public Health and Nursing, Hunt Research Centre, Norwegian University of Science and Technology, Levanger, Norway.
Elin Pettersen SørgjerdDepartment of Public Health and Nursing, NTNU, Hunt Research Centre, Norwegian University of Science and Technology, Levanger, Norway.
Kjell GrankvistDepartment of Medical Biosciences, Umea University, Umeå, Sweden.
Mikael JohanssonDepartment of Radiation Sciences, Oncology, Umea University, Umeå, Sweden.
Neal D FreedmanMetabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Wen-Yi HuangMetabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Chu ChenPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA.
Ross PrenticePublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA.
Victoria L StevensAmerican Cancer Society, Atlanta, USA.
Ying WangAmerican Cancer Society, Atlanta, USA.
Loic Le MarchandUniversity of Hawai'i Cancer Center, University of Hawai'i at Mānoa, Honolulu, USA.
Lynne R WilkensUniversity of Hawai'i Cancer Center, University of Hawai'i at Mānoa, Honolulu, USA.
Stephanie J WeinsteinMetabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Demetrius AlbanesMetabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Qiuyin CaiVanderbilt University Medical Center, Nashville, USA.
William J BlotVanderbilt University Medical Center, Nashville, USA.
Alan A ArslanDepartment of Obstetrics and Gynecology, NYU Langone Health, New York, NY, USA.
Anne Zeleniuch-JacquotteDepartment of Population Health, NYU Langone Health, New York, NY, USA.
Xiao-Ou ShuVanderbilt University Medical Center, Nashville, USA.
Wei ZhengVanderbilt University Medical Center, Nashville, USA.
Jian-Min YuanUniversity of Pittsburgh Medical Center, Pittsburgh, USA.
Woon-Puay KohDuke - NUS Medical School, Singapore, Singapore.
Kala VisvanathanJohns Hopkins Institute for Clinical and Translational Research, Baltimore, USA.
Howard D SessoBrigham and Women's Hospital, Harvard Medical School, Boston, USA.
Xuehong ZhangBrigham and Women's Hospital, Harvard Medical School, Boston, USA.
J Michael GazianoHarvard T.H. Chan School of Public Health, Boston, USA.
Anouar FanidiUniversité Claude Bernard Lyon 1, Lyon, France.
David MullerImperial College London School of Public Health, London, UK.
Paul BrennanGenomic Epidemiology Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008, Lyon, France.
Florence GuidaGenomic Epidemiology Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008, Lyon, France.
Hilary A RobbinsGenomic Epidemiology Branch, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008, Lyon, France. RobbinsH@iarc.fr.
Centre International de Recherche sur le Cancer · FRVanderbilt University Medical Center · USBrigham and Women's Hospital · USNational Cancer Institute · USUmeå University · SEAmerican Cancer Society · USCancer Council Victoria · AUNorwegian University of Science and Technology · NONYU Langone Health · USSeattle University · USUniversity of Hawaiʻi at Mānoa · USBevital (Norway) · NODivision of Cancer Epidemiology and GeneticsDuke-NUS Medical School · SGImperial College London · GBLund University · SESkåne University Hospital · SEUniversité Claude Bernard Lyon 1 · FRUniversity of Bergen · NOUniversity of Pittsburgh Medical Center · US

Funding

Tumor Immunology (TIM) Research ProgramP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · 1985 to 2025
$21.1M
RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · 1985 to 2004
$9.9M
Understanding Population Differences in Cancer: The MEC StudyU01CA164973 · UNIVERSITY OF HAWAII AT MANOA · 2025 to 2025
$4.9M
General Studies of EpidemiologyZIACP010167 · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · 2025 to 2025
$1.5M
Cancer Epidemiology Cohort in Male Health ProfessionalsU01CA167552 · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · 2025 to 2025
$1.5M
NCI NIH HHS P30 CA016087NCI NIH HHS P50 CA127003NCI NIH HHS R01 CA144034NCI NIH HHS U01 CA155340NCI NIH HHS U01 CA164973NCI NIH HHS U01 CA167552NCI NIH HHS U01 CA182934NCI NIH HHS UM1 CA173640NCI NIH HHS UM1 CA182876NCI NIH HHS UM1 CA182910NCI NIH HHS UM1 CA186107NHLBI NIH HHS HHSN268201600001CNHLBI NIH HHS HHSN268201600002CNHLBI NIH HHS HHSN268201600003CNHLBI NIH HHS HHSN268201600004CNHLBI NIH HHS HHSN268201600018CNIEHS NIH HHS P30 ES000260World Health Organization 001
6 · The paper itself

Abstract

Imbalances of blood biomarkers are associated with disease, and biomarkers may also vary non-pathologically across population groups. We described variation in concentrations of biomarkers of one-carbon metabolism, vitamin status, inflammation including tryptophan metabolism, and endothelial and renal function among cancer-free older adults. We analyzed 5167 cancer-free controls aged 40-80 years from 20 cohorts in the Lung Cancer Cohort Consortium (LC3). Centralized biochemical analyses of 40 biomarkers in plasma or serum were performed. We fit multivariable linear mixed effects models to quantify variation in standardized biomarker log-concentrations across four factors: age, sex, smoking status, and body mass index (BMI). Differences in most biomarkers across most factors were small, with 93% (186/200) of analyses showing an estimated difference lower than 0.25 standard-deviations, although most were statistically significant due to large sample size. The largest difference was for creatinine by sex, which was - 0.91 standard-deviations lower in women than men (95%CI - 0.98; - 0.84). The largest difference by age was for total cysteine (0.40 standard-deviation increase per 10-year increase, 95%CI 0.36; 0.43), and by BMI was for C-reactive protein (0.38 standard-deviation increase per 5-kg/m

Indexed as

AgedAged, 80 and overBiomarkersBody Mass IndexCarbonC-Reactive ProteinFemaleHumansInflammationKidneyKynurenineMaleMiddle AgedSmokingSmoking CessationVitaminsBiomarkersCarbonC-Reactive ProteinKynurenineVitamins

Identifiers

PMID34226613
PMCPMC8257595
OpenAlexW3181714582

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.